<DOC>
	<DOCNO>NCT01463306</DOCNO>
	<brief_summary>Study A0081106 12-month open-label study evaluate long term safety tolerability pregabalin add-on therapy pediatric subject 1 month 16 year age partial onset seizure pediatric adult subject 5 65 year age primary generalize tonic-clonic seizure . Pregabalin administer equally divide daily dos 1 year , either capsule liquid oral formulation .</brief_summary>
	<brief_title>A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Subjects and/or parent ( ) /legally acceptable representative must consider willing able sign consent , complete daily dose seizure diary complete schedule visit . Male female epilepsy subject , 1 month 65 year age inclusive date Screening Visit . Diagnosis epilepsy seizure classify simple partial , complex partial , partial become secondarily generalize , primary generalize tonicclonic seizure accord International League Against Epilepsy ( ILAE 2010 ) Diagnosis Criteria . Partial onset seizure subject must average least 3 seizure per 28 day period 3 month prior screen . Currently receive stable dose 1 3 antiepileptic drug ( stable within 28 day prior screen ) . LennoxGastaut syndrome , Infantile Spasms , Absence seizures , BECT ( Benign Epilepsy Centrotemporal Spikes ) , Dravet syndrome , A current diagnosis febrile seizure febrile seizure within 1 year screening . Status epilepticus within 1 year prior visit 1 . Seizures related drug , alcohol , acute medical illness . Progressive structural CNS lesion progressive encephalopathy .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>safety</keyword>
	<keyword>partial onset seizure</keyword>
	<keyword>primary generalize tonic-clonic seizure</keyword>
	<keyword>pregabalin</keyword>
	<keyword>pediatric</keyword>
	<keyword>adult</keyword>
	<keyword>open-label</keyword>
	<keyword>long term</keyword>
</DOC>